It looks like your post got more recommendations than mine so I guess we are cleared to talk about TBP. Good mushroom analogy btw.

Ended the day today at $1.15 (+45%). That is after a run yesterday from $0.60 to $0.75. This may be due to a couple potential news catalysts. (1) Is a notice of authorization from HC to allow trials of topical treatments, (2) Distribution and supply agreement with a company to purchase a minimum of $1.5M of product over 5 years, (3) Exclusive rights to the use of a drug. Or the rise could be nothing but a pump, hype, a natural realization of the company's worth, or other. 

These weed stocks are very strange. Companies with less than $10M/quarter have $2 billion market caps. Lots of speculation and lots of wacky movement. One positive (apart from the gains) is the amount of transparency and communication. Some companies have a monthly update where they release a very brief update of progress. Responses from IR within 24hrs. And their PPs are usually over-subscribed and often raised. Of course POET is totally different for all the reasons we know ("NDA" are they still under that) but it is a curious change.